HTG Molecular Diagnostics

About:

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

Website: http://www.htgmolecular.com

Twitter/X: HTGmolecular

Top Investors: Novo Holdings, Silicon Valley Bank, SR One, Oxford Finance LLC, Fletcher Spaght, Inc.

Description:

HTG Molecular Diagnostics is a provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's NGS-adapted chemistry and HTG EdgeSeq technology automate sample processing and can swiftly, reliably, and concurrently profile hundreds or thousands of molecular targets utilizing a very little quantity of biological material, in liquid or solid form. Its products comprise equipment, consumables, and software that work together to form the HTG EdgeSeq platform. The HTG EdgeSeq platform automates the company's menu of HTG EdgeSeq molecular profiling panels, which use genomic sequencing techniques to swiftly provide gene expression data for clients utilizing its streamlined approach. HTG Molecular Diagnostics was established in 1997 by Bruce E. Seligmann in Tucson, Arizona.